In the present study, we sought to implement the NanoString panel of ALK fusion detection for lung cancer patients, our NanoString results were further compared with immunohistochemistry or FISH analysis of ALK and showed a full concordance of methodologies. The gene discussed is ALK; the disease is lung carcinoma.